Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Multicenter real-world study of CAR T-cell outcomes in RRMM by race finds no significant differences in ORR, response depth, PFS, OS, CRS, or ICANS; bacterial infections are more frequent in WP, while viral slightly more in MP.”
Title: Outcomes of CAR T-Cell therapy in relapsed/refractory multiple myeloma by race: a multicenter real-world study
Authors: Manisha Bhutani, Alma Habib, Andrew Vegel, Ami Ndiaye, Emily Struble, Hira Shaikh, Darryl Chang, Christopher Strouse, Kimberly M. Green, Kevin Graf, Muhammad Umair Mushtaq, Zahra Mahmoudjafari, Joseph P. McGuirk, Peter Voorhees, Abdullah Mohammad Khan, Al-Ola Abdallah, Nausheen Ahmed and Shebli Atrash
You can read the Full Article in Blood Cancer Journal.
You can find more posts featuring Robert Orlowski on OncoDaily.
